Canine Arthritis Treatment Market 2021 Size, Industry Share, Growth, Trends, Scope, Industry Opportunity Analysis and Forecast, 2021-2029 | IMF report with expert review
According to a healthcare expert at Future Market Insights, “Factors such as the increasing prevalence of chronic disease in dogs, increasing adoption of companion animals, increasing consumer spending on veterinary care and rapid approvals of the FDA for drugs used for canine arthritis treatments are expected to boost the dog global. arthritis treatment market during the forecast period. Additionally, dog owners opting for canine stem cell therapy over medicated drugs are the most lucrative segment in terms of investment opportunities. However, safety concerns affecting the clinical efficacy of canine pluripotent cells and high therapy costs limit the uptake of canine stem cell therapy. Autologous stem cells from MediVet approved by the FDA and Aratana’s Galliprant for controlling pain and inflammation associated with arthritis are expected to help the growth of the canine arthritis treatment market.
However, illicit drugs that are falsely registered could restrict the dog treatment market. These drugs are not manufactured according to regulations, inversely affecting the health of the dog associated with the sale of approved drugs. Research shows that counterfeit drugs are more prevalent in underdeveloped and developing countries. Growing penetration of international trade and e-commerce is fueling sales of substandard drugs.
Access research methodology prepared by experts >>> https://www.futuremarketinsights.com/ask-question/rep-gb-3552
Canine insurance and direct drug sales to open up treatment opportunities for canine arthritis
Pet insurance is an upcoming trend, especially in mature economies. With just 1% of dogs insured in the United States, the trend is catching up in the region, opening up opportunities for veterinary insurance providers. However, this number can reach 50% for companion dogs in some European countries. In addition, the introduction of third-party payments is expected to boost the sales of canine arthritis drugs, mainly for NSAIDs and stem cell therapy segments globally, and lead to the creation of new channels of sale for drugs to treat canine arthritis.
In addition, canine health product manufacturers rely on direct sales to end users in an effort to reach a broader consumer base. In addition, by adopting this sales channel, companies are also offering additional training and support in terms of disease management and adherence to treatment protocols.
Key players such as Boehringer Ingelheim, Elanco (Eli Lilly and Company), Zoetis Inc., Bayer AG, Aratana Therapeutics Inc., Vetoquinol SA, Norbrook Laboratories Limited, VetStem Biopharma and Dechra Pharmaceuticals Plc are developing cost-effective drugs for the treatment of canine arthritis. and increasing sales through acquisitions to increase their respective market share. Manufacturers are also focusing on developing new stem cell therapies for the treatment of arthritis. In addition, companies are focusing on partnerships with wholesalers, distributors and other distribution partners to take ownership of the value chain.
Canine Arthritis Treatment Market Segmentation Overview Analysis By Treatment Type – Nonsteroidal Anti-Inflammatory Drugs, Opioids, Stem Cell Therapy; route of administration – Oral, injectable: https: //www.futuremarketinsights.com/reports/canine-arthritis-market
1.1. Market outlook
1.2. Analysis and recommendations
2. Market overview
2.1. Market coverage / taxonomy
2.2. Definition / scope / limits of the market
Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-3552
3. Market context
4. Market context
5. Global Canine Arthritis Treatment Market Analysis (Value or Size in Million US $) 2014-2018 and Forecast, 2019-2029
6. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type
Explore broad IMF coverage Health care Market Information Landscape
IMF Analysis of Psychedelic Medicine Market provides insight into key market trends, strategies, regional players, and various segments based on form, type, application, and region.
Genetic Cardiomyopathies Market Find information on the global market scenario and segmentation on the basis of ingredients, application, source, and region.
The IMF Short Sleep Syndrome Treatment Market report highlights parent market trends and strategies in the market with segments and dynamics throughout the forecast period.
Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in more than 150 countries. IMF is headquartered in Dubai, the world’s financial capital, and has delivery centers in the United States and India. FMI’s latest market research reports and industry analysis help businesses face challenges and make critical decisions with confidence and clarity in a time of fierce competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of analysts led by FMI experts continually monitor emerging trends and events across a wide range of industries to ensure our clients are preparing for the changing needs of their consumers.
Mr. Abhishek Budholiya
Unit number: AU-01-H Gold Tower (AU), Plot number: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
DMCC MARKET ACCESS Initiative
For sales inquiries: firstname.lastname@example.org
For media inquiries: email@example.com